Swiss perspectives in 10 languages

Moderna stands by partnership with Lonza

Lonza
Moderna says it is not abandoning its deal with Lonza. Copyright 2020 The Associated Press. All Rights Reserved.

Despite production of mRNA for the Covid-19 vaccine ending at the Lonza site in Visp, Moderna is maintaining its strategic partnership with the Valais company, assures the boss of the American group. This ten-year partnership was signed in 2020.

“We will discuss possible collaborations as our messenger RNA portfolio materialises,” declared Moderna’s CEO, Stéphane Bancel, in an interview with Le Temps.

He explains that Moderna is “right-sizing its industrial footprint and supply base to accelerate its gross margin expansion toward its long-term goal of 75-80%.” Demand for the vaccine has fallen by 66%, he notes.

The company based in Cambridge, near Boston, in the United States state of Massachusetts plans to absorb demand for mRNA at its Norwood site over the next two years.

In 2025, Moderna plans to expand its capabilities at its new mRNA manufacturing facilities in the United Kingdom, Canada and Australia. Only the manufacturing partnership with Rovi in ​​Spain will be maintained. “At the beginning of this year, we opened a new centre of excellence in Madrid,” notes Stéphane Bancel.

This centre allows analytical tests to be carried out to certify batches of mRNA vaccines for markets outside the United States, he adds. “It makes Spain the largest production centre covering all stages of the Moderna vaccine production chain outside the United States.”

This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles. You can find them here

If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.

External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
Daily news

Get the most important news from Switzerland in your inbox.

Daily

The SBC Privacy Policy provides additional information on how your data is processed.


Popular Stories

Most Discussed

News

Trump names Callista Gingrich ambassador to Switzerland

More

Trump picks Callista Gingrich as ambassador to Switzerland

This content was published on Incoming United States president Donald Trump has named Callista Gingrich as the next ambassador to Switzerland. Gingrich was posted to the Vatican under Trump's previous term.

Read more: Trump picks Callista Gingrich as ambassador to Switzerland

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR